Rejection types are separated by timing and mechanism. Immunosuppressants are paired with their toxicities.
Rejection
- Hyperacute: minutes to hours; preformed antibodies; type II; the graft must be removed.
- Acute cellular: weeks to months; CD8 T cells; reversible with steroids.
- Chronic: months to years; vascular fibrosis and obliterative changes.
- Graft-versus-host disease: donor T cells attack recipient tissue after bone marrow transplant; rash, diarrhea and jaundice.
Drugs
Calcineurin inhibitors (cyclosporine, tacrolimus) block IL-2: nephrotoxicity, hypertension and tremor. Mycophenolate inhibits purine synthesis; azathioprine is metabolized to 6-mercaptopurine and interacts with allopurinol. Sirolimus blocks mTOR; basiliximab blocks IL-2 receptor; glucocorticoids induce apoptosis.
Matching
ABO and HLA matching, particularly HLA-DR, reduce rejection. Cross-matching detects antibodies to donor cells before transplantation.
Keep going in immunology
- Autoimmune diseases and their autoantibodies
- Innate immunity: neutrophils, macrophages and NK cells
- Lymphoid organs and B and T cell development
- Allergy and anaphylaxis: recognition and treatment